Last updated: March 17, 2024
Sponsor: Cheng-Hsin General Hospital
Overall Status: Completed
Phase
2
Condition
Stroke
Cerebral Ischemia
Treatment
Hand of Hope
Botulinum toxin type A injection
Clinical Study ID
NCT04502264
(745)108A-61
Ages 20-85 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Aged between 20-85 year-old
- The onset of stroke must be at least 6 month previously
- The stroke must be the first event
- The stroke must be unilateral brain lesion
- Spasticity measured as Modified Ashworth scale during 1+ to 3
- Score at least 1 point in the wrist subtest of Fugl-Meyer Assessment
- Brunnstrom stage of proximal upper limb at least 3, distal upper limb between 2 to 5
- No impairment in visual tracking ability
- No impairment in proprioception
Exclusion
Exclusion Criteria:
- Severe joints pain of hand or finger at affected limb
- Fracture of affected limb in three months
- Brunnstrom stage of proximal upper limb not more than 2, distal upper limb more than 5
Study Design
Total Participants: 24
Treatment Group(s): 2
Primary Treatment: Hand of Hope
Phase: 2
Study Start date:
January 09, 2020
Estimated Completion Date:
February 09, 2024
Connect with a study center
Cheng-Hsin general hospital
Taipei,
TaiwanSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.